Skip to content
Home - Media - Press releases - 2002    
4 March 2002
ASTRAZENECA PUBLIC OFFER TO PURCHASE REMAINING SHARES IN ASTRAZENECA PHARMA INDIA LTD

AstraZeneca PLC today announced that its subsidiary Astra Pharmaceuticals AB is to make a voluntary public offer in India to purchase the 43.5% of shares in AstraZeneca Pharma India Limited, which it does not already own.

The offer, which is not conditional on any minimum level of acceptances will be open between 29th April 2002 and 28th May 2002. The offer price will be 375 Rps per share payable in cash. The offer price represents a 31% premium on the average price for the week ending 1st March 2002 and a 44% premium on the average price for the previous six months.

AstraZeneca Pharma India Ltd manufactures and markets a range of cardiovascular, inhalation, cough, anaesthetics and maternal healthcare products. The business has 1500 employees.

Further enquires to:

Media Relations

Ross Horsburgh
+65 633 97022

Chris Major
+44 (0)20 7304 5028

AstraZeneca websites
Search